Snowball logo
logo
SPHD

Santhera Pharmaceuticals Holding AG

SPHDF • PINK
$18.30$0.00  (0%)
Estimate
EPS
-4.67
Beta
-0.314
About the company
Ticker
SPHDF
ISIN
CH1276028821
Country
Switzerland
Sector (GICS)
Healthcare
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Frequently asked questions

What sector does Santhera Pharmaceuticals Holding AG (SPHDF) operate in?

Santhera Pharmaceuticals Holding AG belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Santhera Pharmaceuticals Holding AG (SPHDF) current stock price?

As of the latest data, Santhera Pharmaceuticals Holding AG stock price is $18.30, with a previous close of $18.30.

What is Santhera Pharmaceuticals Holding AG (SPHDF) current market capitalization?

Santhera Pharmaceuticals Holding AG market cap is approximately 271.42 million.

What is Santhera Pharmaceuticals Holding AG (SPHDF) Earnings Per Share (EPS)?

The trailing EPS is -$4.67.

Does Santhera Pharmaceuticals Holding AG (SPHDF) pay dividends?

No. Santhera Pharmaceuticals Holding AG does not pay a dividend.

What is Santhera Pharmaceuticals Holding AG (SPHDF) beta (volatility) score?

Santhera Pharmaceuticals Holding AG has a beta of -0.314, indicating lower volatility than the overall market.